Clinical trial
Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
NCT02040246 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
- Lead sponsor
- RenJi Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- January 31, 2014
- Enrollment
- 107 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.